Careers  |  Sign In  |  Register  |   Twitter

Latest in Pathology & Lab Medicine

According to an article published by Reuters, a new breast cancer drug from Swiss pharmaceutical company Roche has been deemed too expensive for routine use and rejected by the British National Health Service (NHS). The new drug, Kadcyla, targets cancer cells directly, eliminating a number of typical...
A second experimental Ebola drug from Tekemira Pharmaceuticals is advancing through clinical trials from healthy volunteers to affected patients in Africa thanks to help from the FDA, the New York Times reports. Last month, the FDA had stopped the trial for TKM-Ebola because of side effects, but taking into...
According to an article published by Reuters, the World Health Organization has declared the Ebola epidemic an international health risk. The virus, which has already killed almost 1,000 people in Africa, could be due to weak healthcare systems in the afflicted countries, in addition to an inadequate...